Margaret Huggins, MD
Obstetrics & Gynecology · Idaho Falls, IDNPI 1215040480
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.3% of the total across 35 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Astellas Pharma US Inc at 29.1% of the total. Reporting peaked in 2024 at $273 and has fallen 55.3% since, to $122 in 2025.
Across 35 payments — averaging $23.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$240
- AbbVie$114
- Myriad Genetic Laboratories, Inc.$107
- Novo Nordisk$62
- Amgen$51
- Biogen$44
- plus $206 from 8 others
What the payments were for
- Food & beverage$81198%
- Education$142%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 8 | $240 |
| AbbVie | 7 | $114 |
| Myriad Genetic Laboratories, Inc. | 1 | $107 |
| Novo Nordisk | 4 | $62 |
| Amgen | 3 | $51 |
| Biogen | 2 | $44 |
| Pfizer | 2 | $40 |
| Johnson & Johnson | 1 | $35 |
| Conmed Corporation | 1 | $33 |
| Shield Therapeutics Inc | 2 | $29 |
| Mycovia Pharmaceuticals, Inc. | 1 | $19 |
| Merck | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Bayer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- myRisk$107
How this compares
$824 in reported general payments places this provider in the 55th percentile of 166 obstetrics & gynecology providers in Idaho.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 67 | $1,561 |
| Levothyroxine Sodium | 99 | $545 |
| Fesoterodine Fumarate ErFesoterodine Fumarate | 13 | $273 |
| Fluconazole | 18 | $231 |
| NitrofurantoinNitrofurantoin Macrocrystal | 14 | $129 |
| Escitalopram Oxalate | 25 | $99 |
| Medroxyprogesterone Acetate | 13 | $88 |
| Simvastatin | 24 | $62 |
| Atorvastatin Calcium | 26 | $61 |
| Bisoprolol-HydrochlorothiazideBisoprolol/Hydrochlorothiazide | 12 | $61 |
| Metoclopramide Hcl | 11 | $47 |
| Hydrochlorothiazide | 17 | $37 |
| Sertraline Hcl | 15 | $21 |
| Potassium Chloride | 12 | $11 |
| Lovastatin | 16 | $5 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Idaho Falls
- Ty EricksonIdaho Falls$286K
- Jeffrey BakerIdaho Falls$18K
- Glenn LeavittIdaho Falls$17K
- Tauni EckersellIdaho Falls$3K
- Jeremy WhitingIdaho Falls$3K
- Steven RobisonIdaho Falls$3K
- Steven AdamsIdaho Falls$2K
- Matthew RobisonIdaho Falls$2K
- Luke O RourkeIdaho Falls$2K
- Kim CoxPocatello$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.